| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 04/30/1996 | US5512457 Cytokine designated elk ligand |
| 04/25/1996 | WO1996012028A1 Production of peptides in plants as viral coat protein fusions |
| 04/25/1996 | WO1996012019A2 Her4 human receptor tyrosine kinase or the epidermal growth factor receptor family |
| 04/25/1996 | WO1996011947A1 Materials for the production of nanometer structures and use thereof |
| 04/25/1996 | WO1996011944A1 Synthetic peptides and vaccines comprising same |
| 04/25/1996 | CA2202533A1 Her4 human receptor tyrosine kinase |
| 04/25/1996 | CA2202474A1 Materials for the production of nanometer structures and use thereof |
| 04/24/1996 | EP0707599A1 Regulation of site-specific recombination by site-specific recombinase/nuclear receptor fusion proteins |
| 04/23/1996 | US5510249 Fusion of signal peptide, a leader peptide, a heterogenous protein or polypeptide; genetic engineering |
| 04/18/1996 | WO1996011274A1 Chimeric papillomavirus-like particles |
| 04/18/1996 | WO1996011272A2 Papilloma virus-like particles, fusion proteins and process for producing the same |
| 04/18/1996 | WO1996011269A2 Tie-2 ligands, methods of making and uses thereof |
| 04/17/1996 | EP0506826B1 Antibody antagonists of human interleukin-4 |
| 04/17/1996 | EP0483194B1 IgG3 ANTIBODIES WITH SHORTENED HINGE REGION AND A COMPLEMENT ACTIVATION TEST |
| 04/17/1996 | EP0424519B1 Antigenes of the envelope transmembrane glycoprotein of a human retrovirus of the hiv-2 type, and antigens presenting with them an immunological relationship |
| 04/17/1996 | EP0290565B1 Vaccine containing tick antigens |
| 04/17/1996 | CN1120547A Method for prepn. of NTPS |
| 04/16/1996 | US5508386 An immunoglobulin molecule containing a tetrapeptide epitope within the third complementarity-determining region in the n-terminus variable domain thereof |
| 04/16/1996 | US5508263 A solid matrix having a protein coatings prepared from culturing two different nucleotide sequences; repairing bone defects |
| 04/11/1996 | WO1996010415A1 Preparation of mhc-peptide complexes |
| 04/11/1996 | WO1996010411A1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 04/11/1996 | CA2201519A1 Preparation of mhc-peptide complexes |
| 04/11/1996 | CA2201498A1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 04/10/1996 | EP0705903A1 In vivo mutations and polymorphisms in the 17q-linked breast and ovarian cancer susceptibility gene |
| 04/10/1996 | EP0705341A1 Hybrid receptor molecules |
| 04/10/1996 | EP0705278A1 Apoptose inhibitor |
| 04/10/1996 | EP0688316A4 Coupling method using selective amination of maleimide |
| 04/10/1996 | CN1120352A Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 04/09/1996 | US5506121 Fusion peptides with binding activity for streptavidin |
| 04/04/1996 | WO1996010041A1 PEPTIDES FROM THE hPTH SEQUENCE (1-37) |
| 04/04/1996 | DE4434551A1 Peptide aus der Sequenz des hPTH (1-37) Peptides from the sequence of hPTH (1-37) |
| 04/03/1996 | EP0704458A2 Anti-human type IV collagen antibodies and use thereof |
| 04/03/1996 | EP0704221A2 A conjugate useful in gene transfer and a method of producing the same |
| 03/27/1996 | EP0702725A1 Method for recombinant production of biologically active polypeptides |
| 03/27/1996 | EP0702724A1 Mengovirus as a vector for expression of foreign polypeptides |
| 03/27/1996 | EP0702721A1 Process for producing fusion proteins comprising scfv fragments by a transformed mould |
| 03/21/1996 | WO1996008513A1 Cytotactin derivatives that stimulate attachment and neurite outgrowth, and methods of making and using same |
| 03/21/1996 | WO1996008512A1 POLYPEPTIDES WITH Fc BINDING ABILITY |
| 03/21/1996 | WO1996008510A1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR |
| 03/21/1996 | WO1996008506A1 Phosphorus-32 labeling of antibodies for cancer therapy |
| 03/21/1996 | WO1996008263A1 Intracellular delivery of chemical agents to a specific cell type |
| 03/21/1996 | DE4432942A1 New synthetic inducible biological response amplifier |
| 03/21/1996 | CA2200088A1 Phosphorus-32 labeling of antibodies for cancer therapy |
| 03/21/1996 | CA2198361A1 Intracellular delivery of chemical agents to a specific cell type |
| 03/21/1996 | CA2198248A1 Polypeptides with fc binding ability |
| 03/20/1996 | EP0702083A2 Polypeptides and fusion proteins that contain the UL57 open reading frame or the C-terminus of tegument protein pp150 from HCMV, corresponding oligonucleotides and diagnostic test kits |
| 03/20/1996 | EP0701572A1 Composite synthetic peptide construct eliciting neutralizing antibodies and cytotoxic t lymphocytes against hiv |
| 03/20/1996 | EP0701569A1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome |
| 03/19/1996 | US5500362 Chimeric antibody with specificity to human B cell surface antigen |
| 03/19/1996 | US5500347 Diagnosis of cancerous tumors and determination of their origin |
| 03/14/1996 | WO1996007741A1 Protein targeting into hiv virions based on hiv-1 vpr fusion molecules |
| 03/14/1996 | WO1996005306A3 In vivo mutations and polymorphisms in the 17q-linked breast and ovarian cancer susceptibility gene |
| 03/14/1996 | WO1996004378A3 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
| 03/14/1996 | CA2198621A1 Protein targeting into hiv virions based on hiv-1 vpr fusion molecules |
| 03/13/1996 | EP0700997A1 Production in bacteria and yeast of hemoglobin and analogues thereof |
| 03/13/1996 | EP0700993A1 Anti-thymosin alpha 1 monoclonal antibody-producing hybridoma |
| 03/13/1996 | EP0700933A1 Microsphere-based biotin-latex, process for the manufacture of such microspheres and use thereof as biological detecting agents |
| 03/13/1996 | EP0700445A1 Stress proteins and uses therefor |
| 03/13/1996 | EP0700444A1 Immunotoxins comprising gelonin and an antibody |
| 03/13/1996 | EP0700438A1 Opioid receptors: compositions and methods |
| 03/13/1996 | EP0428602B1 Polypeptides and dna encoding same |
| 03/10/1996 | CA2157811A1 Biotinylated latex microsphere; process for preparing the same and use thereof as a biological detector |
| 03/10/1996 | CA2145905A1 Anti-thymosin .alpha.1 monoclonal antibody-producing hybridoma |
| 03/07/1996 | DE19532001A1 New antibacterial peptide, moricin, from silkworms |
| 03/06/1996 | EP0699907A2 Diagnostic methods soluble CD8 T cell surface antigen and anti-CD8 antibody |
| 03/06/1996 | EP0699766A1 Therapeutic antibody based fusion proteins with platelet factor-4 |
| 03/06/1996 | EP0699756A1 Novel mutant BR96 antibodies and functional equivalents reactive with human carcinomas |
| 03/06/1996 | EP0699755A2 Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains, compositions containing them |
| 03/06/1996 | EP0699305A1 Methods, agents and kits for detection of organophosphorus compounds |
| 03/06/1996 | EP0699077A1 Hiv immunogenic complexes |
| 03/06/1996 | EP0476059B1 Methods for enhancing the rate of modification of metastable bonds |
| 03/06/1996 | EP0449955B1 Synthetic hiv-like peptides, their compositions and uses |
| 03/06/1996 | EP0387319B1 Secretory leader sequences |
| 03/06/1996 | CN1117873A Usage of follicle-stimulating hormone |
| 03/05/1996 | US5496551 Polypeptide immunogens |
| 02/29/1996 | WO1996006159A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 02/29/1996 | WO1996006111A1 Regulatable elimination of gene expression, gene product function and engineered host cells |
| 02/29/1996 | CA2197242A1 Regulatable elimination of gene expression, gene product function and engineered host cells |
| 02/29/1996 | CA2196892A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 02/28/1996 | EP0698101A1 Hepatitis-c virus type 4, 5 and 6 |
| 02/27/1996 | US5494672 Pseudomonas peptide composition and method |
| 02/22/1996 | WO1996005306A2 IN VIVO MUTATIONS AND POLYMORPHISMS IN THE 17q-LINKED BREAST AND OVARIAN CANCER SUSCEPTIBILITY GENE |
| 02/21/1996 | EP0516785B1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF alpha |
| 02/20/1996 | US5492893 Sterilization of animals; therapy od sex hormone relateddiseases |
| 02/20/1996 | US5492890 Polypeptides for promoting cell attachment |
| 02/20/1996 | US5492314 Preloaded digressive rate mount |
| 02/15/1996 | WO1996004388A1 Novel compounds |
| 02/15/1996 | WO1996004378A2 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
| 02/15/1996 | WO1996004314A1 Mhc complexes and uses thereof |
| 02/15/1996 | WO1996003883A1 Cells bearing cd4 decoy receptors and related molecules and methods |
| 02/15/1996 | WO1996002645A3 Htk ligand |
| 02/15/1996 | CA2196290A1 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
| 02/15/1996 | CA2196200A1 Novel compounds |
| 02/13/1996 | US5491088 Genetic engineering |
| 02/13/1996 | US5491073 Cloning of chicken anaemia DNA |
| 02/08/1996 | WO1996003522A1 Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same |
| 02/08/1996 | WO1996003519A1 Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same |
| 02/08/1996 | WO1996003501A1 Dual hybrid system |
| 02/08/1996 | WO1996003141A1 Pharmaceutical compositions comprising a chimaeric tnf binding protein |
| 02/08/1996 | CA2195665A1 Pharmaceutical compositions comprising a chimaeric tnf binding protein |